Dr Reddys Laboratories (RDY) EBIT Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded EBIT Margin of 4.69% in the quarter ended Jun 30, 2026, down 15.76 percentage points from 20.45% a year earlier and down 32.04 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) EBIT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' EBIT Margin came in at 22.02% as of Jun 30, 2026, up 5.77 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 15.06%, down 7.01 percentage points from the prior year.
- Annual EBIT Margin has a five-year change of +2.26 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, EBIT Margin came in at 22.07% in the year ended Mar 31, 2025 (-2.20 pp), 24.27% in the year ended Mar 31, 2024 (+1.04 pp), 23.23% in the year ended Mar 31, 2023 (+9.46 pp) and 13.77% in the year ended Mar 31, 2022 (+0.97 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBIT Margin since the quarter ended Mar 31, 2025.
- On a year-over-year basis, EBIT Margin rose in three of the last eight quarters, with an average year-over-year change of +4.77 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 36.47 percentage points in the quarter ended Mar 31, 2026, against a drop of 25.71 percentage points in the quarter ended Mar 31, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 36.73% (quarter ended Mar 31, 2026), 26.94% (quarter ended Dec 31, 2025) and 19.89% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 4.69% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.69% |
| Mar 31, 2026 | 36.73% |
| Dec 31, 2025 | 26.94% |
| Sep 30, 2025 | 19.89% |
| Jun 30, 2025 | 20.45% |
| Mar 31, 2025 | 0.26% |
| Dec 31, 2024 | 22.40% |
| Sep 30, 2024 | 21.89% |
| Jun 30, 2024 | 23.36% |
| Mar 31, 2024 | 0.43% |
| Dec 31, 2023 | 0.30% |
| Sep 30, 2023 | 25.97% |
| Jun 30, 2023 | 25.97% |
| Mar 31, 2023 | 26.14% |
| Dec 31, 2022 | 19.69% |
| Sep 30, 2022 | 24.27% |
| Jun 30, 2022 | 23.42% |
| Mar 31, 2022 | 2.79% |
| Dec 31, 2021 | 10.46% |
| Sep 30, 2021 | 17.40% |
Dr Reddys Laboratories EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();